Researchers Uncover Gene's Role In Severity Of Drinking
Posted on: Wednesday, 4 February 2009, 16:10 CST
Findings Could Lead to More Personalized Alcohol Treatment Methods
New research from the University of Virginia Health System could help explain why some alcoholics are more severe drinkers than others. A UVA team has found strong evidence that the serotonin transporter gene, SLC6A4, plays a significant role in influencing drinking intensity among alcohol-dependent individuals.
The study, published in the February 2009 issue of Alcoholism: Clinical & Experimental Research, analyzed the associations between six different DNA sequence variations, or single nucleotide polymorphisms, of the serotonin transporter gene with the levels of drinking intensity among 275 alcohol-dependent individuals seeking treatment. Drinking intensity is measured by the amount a person consumes each day he or she drinks.
"Of the six variants examined in the study, we found that one variant at the 3' end of the gene showed a significant association with drinking intensity," says study co-author Ming D. Li, Ph.D., professor of psychiatry and neurobehavioral sciences in the UVA School of Medicine. "Specifically, we found that individuals with the 'G' allele of this variant drink less than individuals with the ‘T' allele."
Previous studies have shown that the neurochemical serotonin mediates the rewarding effects of alcohol and, therefore, may be a key contributor leading to alcohol abuse. Studies also show that the brain's serotonin system plays an important role in alcohol preference and consumption.
"Acute drinking increases serotonin release and signaling in brain regions involved in controlling consumption of alcohol," explains study co-author Professor Bankole Johnson, D.Sc., M.D., Ph.D., M.Phil., FRCPsych., chairman of the Department of Psychiatry and Neurobehavioral Sciences in the UVA School of Medicine. "But chronic drinking reduces serotonergic function, leading to a serotonin-deficient state. One hypothesis is that alcoholics drink to alleviate this serotonin-deficient state.
"But it's important to remember that alcoholics differ significantly in their drinking patterns, social backgrounds and disease etiology," says Johnson. "All of these factors may affect both treatment outcomes and medical complications resulting from heavy drinking."
One of the main goals of treatment, Johnson points out, is to reduce the intensity of drinking. "A known genetic marker could be used to sub-type alcoholics and better determine treatment methods that can target specific underlying molecular mechanisms. We hope to determine whether this particular genetic variant can be used as a marker to predict treatment outcomes for different serotonin agents," says Johnson.
---
On the Net:
Related Articles
- Scientists Compare Different Systems Of Measuring Treatment Intensity In Hypertension Care
- Focus on the World Drinking &Amp; Wastewater Treatment Chemicals Market
- Early Drinking Predicts Alcohol Dependence
- FDA Approves Additional Dosage Strengths of Shire's ADHD Treatment VYVANSE(TM) (Lisdexamfetamine Dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
- California Drug and Alcohol Clinic Becomes the First in the Nation to Offer DNA-Customized Treatment for Individuals With a Genetic Predisposition for Addictive Behavior
- AIM-Quoted Verona Pharma Progresses Anti-Asthma Drug Studies
- Strategic Business Report Examines Drinking and Wastewater Treatment Chemicals
- Hope Taft Seeks End to Youths' Drinking: Underage Alcohol Use in Ohio is 2nd in U.S.
- DRINK: What Alcohol Really Does to Your Body
- Associations of Mortality and Diabetes Complications in Patients With Type 1 and Type 2 Diabetes: Early Treatment Diabetic Retinopathy Study Report No. 27
User Comments (0)

RSS Feeds